Lifecore Biomedical (LFCR) Institutional Ownership → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free LFCR Stock Alerts $6.60 -0.04 (-0.60%) (As of 04/26/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Lifecore Biomedical (NASDAQ:LFCR)CurrentInstitutional OwnershipPercentage83.36%Number ofInstitutional Buyers(last 12 months)19TotalInstitutional Inflows(last 12 months)$31.16MNumber ofInstitutional Sellers(last 12 months)9TotalInstitutional Outflows(last 12 months)$12.03M Get LFCR Insider Trade Alerts Want to know when executives and insiders are buying or selling Lifecore Biomedical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LFCR Institutional Buying and Selling by Quarter Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy Lifecore Biomedical Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/15/2024Greenhaven Road Investment Management L.P.2,366,956$14.65M6.6%+7.9%7.806% 2/14/2024Visionary Wealth Advisors497,204$3.08M0.2%-0.8%1.640% 2/13/2024DCF Advisers LLC259,684$1.61M0.9%+115.1%0.856% 2/12/2024Cove Street Capital LLC910,264$5.64M1.7%-17.7%3.002% 2/1/2024Cutter & CO Brokerage Inc.15,567$96K0.0%-28.3%0.051% 1/30/2024 Keene & Associates Inc.21,935$136K0.1%-8.4%0.072% Get the Latest News and Ratings for LFCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lifecore Biomedical and its competitors with MarketBeat's FREE daily newsletter. 12/6/2023Citigroup Inc.33,618$254K0.0%+2,311.6%0.111% 11/21/2023Greenhaven Road Investment Management L.P.2,193,333$16.55M8.4%+15.3%7.234% 11/14/2023Trexquant Investment LP47,157$356K0.0%N/A0.156% 11/13/2023Visionary Wealth Advisors501,334$3.78M0.3%+0.4%1.653% 11/9/2023HAP Trading LLC163,773$1.24M0.2%-82.6%0.540% 11/9/2023Cove Street Capital LLC1,105,556$8.35M2.8%-31.7%3.646% 11/9/2023Tocqueville Asset Management L.P.401,700$3.03M0.1%-11.1%1.325% 11/8/2023Oppenheimer Asset Management Inc.33,532$253K0.0%-48.4%0.111% 11/7/2023Barclays PLC30,911$233K0.0%+244.8%0.102% 11/7/2023Jump Financial LLC36,918$279K0.0%N/A0.122% 11/6/2023 Assenagon Asset Management S.A.23,852$180K0.0%-68.4%0.079% 10/24/2023Bank of New York Mellon Corp24,615$186K0.0%-7.9%0.081% 9/21/2023Barclays PLC8,965$87K0.0%N/A0.030% 8/15/2023Corsair Capital Management L.P.122,431$1.18M0.4%N/A0.404% 8/11/2023Cove Street Capital LLC1,619,536$15.66M4.9%N/A5.341% 8/11/2023Visionary Wealth Advisors499,309$4.83M0.4%N/A1.647% 8/10/2023Gamco Investors INC. ET AL76,500$740K0.0%N/A0.252% 8/10/2023Gabelli Funds LLC16,600$161K0.0%N/A0.055% 8/7/2023Mirabella Financial Services LLP15,413$149K0.0%N/A0.051% 8/3/2023Oppenheimer Asset Management Inc.64,975$628K0.0%N/A0.214% 8/1/2023Cutter & CO Brokerage Inc.21,700$210K0.1%N/A0.072% 7/26/2023 Keene & Associates Inc.24,100$233K0.2%N/A0.079% 7/25/2023 Assenagon Asset Management S.A.75,391$729K0.0%N/A0.249% 7/18/2023Defender Capital LLC.86,450$836K0.3%N/A0.285% 7/18/2023 Diversified Trust Co46,062$445K0.0%N/A0.152% 6/1/2023Prelude Capital Management LLC21,295$80K0.0%N/A0.070% (Data available from 1/1/2016 forward) LFCR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LFCR shares? During the previous two years, 22 institutional investors and hedge funds held shares of Lifecore Biomedical. The most heavily invested institutionals were Greenhaven Road Investment Management L.P. ($14.65M), Cove Street Capital LLC ($5.64M), Visionary Wealth Advisors ($3.08M), Tocqueville Asset Management L.P. ($3.03M), DCF Advisers LLC ($1.61M), HAP Trading LLC ($1.24M), and Corsair Capital Management L.P. ($1.18M).Learn more on LFCR's institutional investors. What percentage of Lifecore Biomedical stock is owned by institutional investors? 83.36% of Lifecore Biomedical stock is owned by institutional investors. Learn more on LFCR's institutional investor holdings. Which institutional investors have been buying Lifecore Biomedical stock? Of the 19 institutional investors that purchased Lifecore Biomedical stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Cove Street Capital LLC ($1.62M), Visionary Wealth Advisors ($501.33K), Greenhaven Road Investment Management L.P. ($464.32K), DCF Advisers LLC ($138.93K), Corsair Capital Management L.P. ($122.43K), Defender Capital LLC. ($86.45K), and Gamco Investors INC. ET AL ($76.50K). How much institutional buying is happening at Lifecore Biomedical? Institutional investors have bought a total of 3,442,244 shares in the last 24 months. This purchase volume represents approximately $31.16M in transactions. Which Lifecore Biomedical major shareholders have been selling company stock? Of the 9 institutional investors that sold Lifecore Biomedical stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: HAP Trading LLC ($775.53K), Cove Street Capital LLC ($709.27K), Assenagon Asset Management S.A. ($51.54K), Tocqueville Asset Management L.P. ($50K), Oppenheimer Asset Management Inc. ($31.44K), Cutter & CO Brokerage Inc. ($6.13K), and Visionary Wealth Advisors ($4.13K). How much institutional selling is happening at Lifecore Biomedical? Institutional investors have sold a total of 1,632,149 shares in the last 24 months. This volume of shares sold represents approximately $12.03M in transactions. Related Companies: Trevi Therapeutics Institutional Ownership Zevra Therapeutics Institutional Ownership Rigel Pharmaceuticals Institutional Ownership Organigram Institutional Ownership Alimera Sciences Institutional Ownership Atossa Therapeutics Institutional Ownership Veru Institutional Ownership Design Therapeutics Institutional Ownership Galectin Therapeutics Institutional Ownership Omeros Institutional Ownership This page (NASDAQ:LFCR) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press4 Cryptos BETTER than BitcoinTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lifecore Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.